Acura Pharmaceuticals Stock (OTCMKTS:ACUR)

USA |OTCQB |USD

Price
$ 0.50
Change
-0.20%
Today's Range
$ 0.46 - $ 0.52
52-Week Range
$ 0.25 - $ 0.74
Market Cap
$ 32.48M
Volume
3.00K

About Acura Pharmaceuticals (OTCMKTS:ACUR)

(OTCMKTS:ACUR) Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was founded in 1935 and is based in Palatine, Illinois.
Show more

ACUR Stock Price

Statistics Highlights (OTCMKTS:ACUR)

Shares Outstanding 65.09M Beta 0.44
Public Float 9.45M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 18.66% Ex-Dividend Date
Held by Institutions 3.01% IPO Date -

ACUR Financial Summary

|
Dec 20 Dec 19 Dec 18
Revenue $3.57M $2.66M $410.00K
EBITDA $-633.00K $-3.04M $-3.17M
Net Income $-1.21M $-3.77M $-3.84M
Total Assets $1.74M $2.56M $2.15M
Total Cash $413.00K $862.00K $91.00K
Total Debt $ $ $
Sep 21 Jun 21 Mar 21
Revenue $270.00K $613.00K $644.00K
EBITDA $-235.00K $-282.00K $-128.00K
Net Income $-262.00K $-387.00K $-259.00K
Total Assets $1.41M $1.90M $1.92M
Total Cash $89.00K $167.00K $361.00K
Total Debt $ $ $

(OTCMKTS:ACUR) Stock Price FAQs

What is today's stock price of Acura Pharmaceuticals (OTCMKTS:ACUR)?

  • The current stock price of Acura Pharmaceuticals (OTCMKTS:ACUR) is $0.50.
  • Today ACUR stock price opened at $0.48 after previous close of $0.50.
  • During the day, Acura Pharmaceuticals stock quote has varied from a low of $0.46 to a high of $0.52.

What is Acura Pharmaceuticals's 52-week change?

  • ACUR 52-week high stock quote is $0.74, which is 48.30% above the current share price.
  • The Acura Pharmaceuticals (OTCMKTS:ACUR) 52-week low stock price is $0.25, which is 49.90% below the current share price.
  • Acura Pharmaceuticals share price volatility (52-week beta) is 0.44.

Acura Pharmaceuticals (OTCMKTS:ACUR) FAQ

How Much is Acura pharmaceuticals Worth?

Acura pharmaceuticals's worth today based on market capitalisation is $32.48M

How much dividend does Acura pharmaceuticals Pay?

The current annualized dividend payout for ACUR stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Acura pharmaceuticals's "Dividend" Section

What is Acura pharmaceuticals’s Price to Earning (PE) ratio?

ACUR stock also has a Price to Sales (P/S) ratio of 14.47, a Price to Book of 231.43 and Price/Earnings to Growth (PEG) of 0.00.

What is the Acura pharmaceuticals's ticker?

Acura pharmaceuticals trades on the OTC Markets stock market in USA under the ticker symbol "ACUR". Acura pharmaceuticals’s stock symbol can also be displayed as "OTCMKTS:ACUR".

Who are the owners of Acura pharmaceuticals?

Acura pharmaceuticals (OTCMKTS:ACUR) is owned by 3.01% institutional shareholders and by 18.66% insiders. The rest is owned by the public.
Explore More Details on Acura pharmaceuticals's “Ownership” Section

Who are the key executives of Acura pharmaceuticals (ACUR)?

Acura pharmaceuticals's key executive team includes the following managers:

  • Mr. Robert B. Jones, CEO, Pres & Director (1959)
  • Mr. Peter A. Clemens, Sr. VP, CFO & Sec. (1953)
  • Dr. Albert W. Brzeczko, VP of Pharmaceutical Sciences of Acura Pharmaceutical Technologies, Inc. (1957)
  • Mr. Robert A. Seiser CPA, Ph.D., VP, Treasurer & Corp. Controller (1964)

What is Acura pharmaceuticals’s Sector & Industry Classification?

Acura pharmaceuticals (OTCMKTS:ACUR) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Acura pharmaceuticals?

Currently the number of employees working for Acura pharmaceuticals is 12.

Where are Acura pharmaceuticals's Headquarters?

Acura pharmaceuticals (OTCMKTS:ACUR) is headquartered in IL, United States.

What are Acura pharmaceuticals's Address and Phone Number?

Acura pharmaceuticals’s mailing address is 616 N. North Court, Palatine, IL, United States, 60067.
The company’s phone number is 847 705 7709.

What is the official website for Acura pharmaceuticals?

Acura pharmaceuticals’s official website is http://www.acurapharm.com